Prestigious Award Recognizes Groundbreaking Immune System Discoveries

The prestigious award in medical science was awarded for transformative discoveries that clarify how the immune system attacks harmful infections while sparing the healthy tissues.

Three renowned scientists—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

The work identified unique "security guards" within the defense system that remove rogue defense cells that could attacking the body.

The findings are now enabling innovative therapies for autoimmune diseases and malignancies.

The laureates will share a monetary award worth 11 million SEK.

Decisive Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we do not all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

This team's studies address a core question: In what way does the immune system protect us from countless infections while keeping our healthy cells unharmed?

The immune system employs immune cells that search for signs of disease, including viruses and bacteria it has never encountered.

Such cells utilize detectors—called receptors—that are generated randomly in a vast number of combinations.

This gives the immune system the ability to fight a wide array of invaders, but the randomness of the process inevitably creates immune cells that can attack the host.

Security Guards of the Immune System

Researchers previously knew that some of these problematic white blood cells were destroyed in the thymus—the site where white blood cells develop.

The latest Nobel Prize recognizes the identification of T-reg cells—described as the immune system's "peacekeepers"—which travel through the system to neutralize other defenders that attack the body's own tissues.

It is known that this process fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "The findings have established a new field of investigation and spurred the creation of new therapies, for example for tumors and autoimmune diseases."

In cancer, regulatory T-cells block the system from attacking the tumor, so research are aimed at lowering their numbers.

For autoimmune diseases, trials are testing boosting regulatory T-cells so the organism is not under attack. A similar method could also be useful in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Shimon Sakaguchi, of a Japanese institution, performed tests on rodents that had their thymus extracted, leading to self-attack conditions.

He demonstrated that injecting defense cells from other mice could stop the illness—suggesting there was a mechanism for preventing defenders from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in mice and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking work has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a leading biological science specialist.

"This research is a remarkable example of how fundamental biological research can have far-reaching implications for public health."